Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1R.
Nguyen HT, Kan EL, Humayun M, Gurvich N, Offeddu GS, Wan Z, Coughlin MF, Renteria DC, Loew A, Wilson S, Zhang C, Vu V, Lee SWL, Tan SL, Barbie D, Hsu J, Gillrie MR, Kamm RD. Nguyen HT, et al. Among authors: gillrie mr. Biomaterials. 2025 Jan;312:122731. doi: 10.1016/j.biomaterials.2024.122731. Epub 2024 Jul 30. Biomaterials. 2025. PMID: 39153324
Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R.
Nguyen HT, Gurvich N, Gillrie MR, Offeddu G, Humayun M, Kan EL, Wan Z, Coughlin MF, Zhang C, Vu V, Lee SWL, Tan SL, Barbie D, Hsu J, Kamm RD. Nguyen HT, et al. Among authors: gillrie mr. bioRxiv [Preprint]. 2023 Nov 29:2023.11.28.568627. doi: 10.1101/2023.11.28.568627. bioRxiv. 2023. Update in: Biomaterials. 2025 Jan;312:122731. doi: 10.1016/j.biomaterials.2024.122731 PMID: 38076998 Free PMC article. Updated. Preprint.
Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS, Huntley K, Berenger BM, Bristow M, Evans DH, Fonseca K, Franko A, Gillrie MR, Lin YC, Povitz M, Shafey M, Conly JM, Tremblay A. Thornton CS, et al. Among authors: gillrie mr. Antimicrob Resist Infect Control. 2022 Feb 5;11(1):28. doi: 10.1186/s13756-022-01067-1. Antimicrob Resist Infect Control. 2022. PMID: 35123573 Free PMC article.
Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LGN, Dufour A, Bromley A, McDonald B, Gillrie MR, Fritzler MJ, Yipp BG, Biernaskie J. Sinha S, et al. Among authors: gillrie mr. Nat Med. 2022 Jan;28(1):201-211. doi: 10.1038/s41591-021-01576-3. Epub 2021 Nov 15. Nat Med. 2022. PMID: 34782790 Free PMC article.
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Áinle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, Jüni P; RAPID trial investigators. Sholzberg M, et al. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. BMJ. 2021. PMID: 34649864 Free PMC article. Clinical Trial.
25 results